Author

V. Saini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

N. C. Ammerman· 2 shared A. J. Steyn· 1 shared A. Kaushik· 1 shared B. E. Truebody· 1 shared D. A. Lamprecht· 1 shared E. Nuermberger· 1 shared E. Nuermburger· 1 shared I. Vervoort· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

N. C. Ammerman

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mycobacterium tuberculosis H2S functions as a sink to modulate central metabolism, bioenergetics, and drug susceptibility

T. T. R. Kunota, M. A. Rahman, B. E. Truebody, J. S. Mackenzie, V. Saini, D. A. Lamprecht, J. H. Adamson, R. R. Sevalkar, J. R. Lancaster, M. Berney, J. N. Glasgow, A. J. Steyn

This study identifies H2S as an endogenous molecule in M. tuberculosis that modulates metabolism, bioenergetics, and drug susceptibility.

bioRxiv · Jun 2, 2021Microbiology

Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis

V. Saini, N. C. Ammerman, Y. S. Chang, R. Tasneen, R. Chaisson, S. K. Jain, E. Nuermburger, J. H. Grosset

This study tests a new TB treatment regimen combining high-dose rifapentine and clofazimine in mouse models, finding it more effective than either drug alone in shortening treatment duration.

bioRxiv · Feb 21, 2019Microbiology

Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection

A. Kaushik, N. C. Ammerman, S. TYAGI, V. Saini, I. Vervoort, S. Lachau-Durand, E. Nuermberger, K. Andries

This study evaluates a long-acting injectable bedaquiline formulation in a mouse model of latent tuberculosis, showing its efficacy with fewer doses compared to daily oral regimens.

bioRxiv · Jan 9, 2019Microbiology